Northpond Ventures
Investor profile
Venture capital
Deals
8
distinct rounds
Companies
7
backed
Active span
2018–2022
5 yrs
Total round €
€356M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- 1kx1
- Amadeus Capital Partners1
- Backed VC1
- Balaji Srinivasan1
- Boom Capital1
- Borealis Ventures1
- BoxGroup1
- Bristol Myers Squibb1
- Chimera Partners1
- Chris Leiter1
- Compound VC1
- Delin Ventures1
- Fifty Years1
- Founders Fund1
- GV1
- Healthspan Capital1
- Inflection1
- KdT Ventures1
- Koji Capital1
- L1 Digital1
- Lifeforce Capital1
- Longitude Capital1
- Magnetic Ventures1
- Menlo Ventures1
- Novalis LifeSciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ori Biotech | UK | 2 | €114M |
| OMass Therapeutics | UK | 1 | €90M |
| Transition Bio | UK | 1 | €47M |
| Opna Bio | Switzerland | 1 | €37M |
| Current Health | UK | 1 | €36M |
| Teckro | Ireland | 1 | €22M |
| Molecule | Germany | 1 | €12M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Ori Biotech | Series B | €88M | 2022-01 |
| Transition Bio | Series A | €47M | 2022-06 |
| Opna Bio | Series A | €37M | 2022-11 |
| Current Health | Series B | €36M | 2021-04 |
| Ori Biotech | Series A | €26M | 2020-10 |
| Teckro | Series C | €22M | 2018-12 |
| Molecule | Other | €12M | 2022-06 |